课题基金 / 基金详情

Investigating host kinase modulation of erythrocyte deformability during Plasmodium falciparum invasion

Investigating host kinase modulation of erythrocyte deformability during Plasmodium falciparum invasion
研究恶性疟原虫入侵期间红细胞变形能力的宿主激酶调节
批准号:
10431764
负责人:
Patrice Valerie Groomes
金额:
$3.2万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2022-05-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要 疟疾是一种毁灭性的疾病,由专性细胞内疟原虫引起,感染数百万人 每年的人数:仅2017年,就有2.19亿人感染了这种寄生虫,43.5万人感染了这种寄生虫 被杀了。到目前为止,部署的每一种抗疟疾药物都被耐药病例抵消,突显出 迫切需要新的药物靶点。靶向宿主因素是一种未被探索的替代方法 增加疟疾抗药性的障碍。这一战略有可能发现 由于寄主要求的重叠,多个疟原虫物种。此外,许多疟原虫宿主因素 已经是FDA批准的药物靶点,这为药物再用途提供了一个令人信服的理由。 在疟原虫入侵期间,红细胞(RBC)不是一个被动的旁观者;越来越多的证据 提示RBC宿主在寄生虫附着和入侵期间改变了自己的变形性 降低寄生虫进入的能源成本。这些变化是由红细胞细胞骨架的磷酸化驱动的。 宿主RBC激酶TRPM7、酪蛋白激酶II(CKII)和Syk是FDA批准的药物靶点 在恶性疟原虫入侵过程中使红细胞细胞骨架磷酸化。我推测疟原虫信号传递给 裂殖子入侵过程中的红细胞细胞骨架通过这些蛋白来调节红细胞的变形能力。 并便于寄生虫进入。我的初步数据显示,恶性疟原虫的入侵效率受到了影响 在针对TRPM7、CSNK2A1和SYK激酶的单个RBC基因敲除中。 利用基因、化学遗传和磷蛋白质组学的综合方法,该提案寻求 研究TRPM7、CKII和Syk激酶在恶性疟原虫入侵过程中对红细胞变形的作用, 验证以这些激酶为靶点的小分子抑制剂,并阐明寄生虫刺激和下游 恶性疟原虫入侵过程中宿主激酶信号转导的效应分子。如果成功,这些研究 将揭示更多关于疟原虫入侵的基本生物学,确定有希望的药物宿主靶点 在血液期疟疾中改变用途,并促进开发广谱抗疟疾化合物 随着抗药性障碍的增加。最后,由于许多额外的血液疾病会受到 这些酶-包括大血小板减少和动脉纤维化(TRPM7),遗传性球形细胞增多症和 链球菌介导的溶血(Syk)和几种血液系统恶性肿瘤(CKII)-收集的见解 这些功能分析将使寄生虫学和血液学社区受益。 这项拟议的研究将作为我在哈佛大学T.H.的博士论文研究的一部分进行。 陈氏公共卫生学院。在此期间,我将获得并加强包括化学技术在内的技术技能 遗传学、寄生虫学和蛋白质组学;以及微调数据分析、科学交流、指导和 具备专业发展技能,才能成为一名工业领域的独立研究科学家。
英文摘要
PROJECT SUMMARY/ABSTRACT Malaria is a devastating disease caused by obligate intracellular Plasmodium parasites that infect millions of people every year: In 2017 alone, 219 million people were infected by the parasite and 435,000 people were killed. Every antimalarial deployed to date has been counteracted by cases of drug resistance, highlighting a desperate need for novel drug targets.Targeting host factors is an underexplored alternative approach to increasing barriers to drug resistance in malaria. This strategy has the potential to uncover targets required for multiple Plasmodium species due to overlaps in host requirements. Additionally, many Plasmodium host factors are already FDA approved drug targets, making a compelling case for drug repurposing. The red blood cell (RBC) is not a passive bystander during Plasmodium invasion; mounting evidence suggests the RBC host is co-opted into modifying its own deformability during parasite attachment & invasion to reduce the energy costs of parasite entry. These changes are driven by phosphorylation of the RBC cytoskeleton. Host RBC kinases TRPM7, Casein Kinase II (CKII), and Syk are FDA approved drug targets postulated to phosphorylate the RBC cytoskeleton during P. falciparum invasion. I hypothesize that Plasmodium signaling to the RBC cytoskeleton during merozoite invasion occurs through these kinases to modulate RBC deformability and facilitate parasite entry. My preliminary data indicates that P. falciparum invasion efficiency is compromised in individual RBC knockouts targeting TRPM7, CSNK2A1, and SYK kinases. Using an integrated genetic, chemical genetic, and phosphoproteomics approach, this proposal seeks to investigate TRPM7, CKII, and Syk kinase contributions to RBC deformation during P. falciparum invasion, validate small molecule inhibitors targeting these kinases, and elucidate parasite stimuli and downstream effectors mediating host kinase signal transduction during P. falciparum invasion. If successful, these studies will uncover more about the basic biology of Plasmodium invasion, identify promising host targets for drug repurposing in blood stage malaria, and facilitate the development of broad spectrum antimalarial compounds with increased barriers to drug resistance. Finally, as many additional hematological disorders are affected by these kinases—including macrothrombocytopenia & arterial fibrosis (TRPM7), hereditary spherocytosis & Streptococcus-mediates hemolysis (Syk), and several hematological malignancies (CKII)—insights gleaned from these functional analyses will benefit both parasitology and hematology communities. The proposed research will be carried out as part of my doctoral dissertation studies at the Harvard T.H. Chan School of Public Health. During this fellowship I will acquire & strengthen technical skills including chemical genetics, parasitology, and proteomics; and fine-tune data analysis, scientific communication, mentorship, and professional development skills needed to become an independent research scientist in industry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
由actomyosin介导的集体性细胞迁移对唇腭裂发生的影响的研究
  • 批准号:
    82360313
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    滕藤
  • 依托单位: